Nama's AI scorecard currently rates Autodesk Buy (8.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is ADSK's P/E ratio?

Autodesk trades at a trailing price-to-earnings ratio of 22.2.

When does ADSK report earnings?

Autodesk's next scheduled report is on Nov 27, 2026. Analysts expect EPS of $3.07.

What is the ADSK price target?

The median analyst price target from 34 analysts is $302.50, with a range of $215.00 – $375.00.

Is ADSK Shariah compliant?

Nama's AAOIFI-style screen reads Autodesk as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Autodesk (ADSK)

Technology · Software Application · NASDAQ

S&P 500Nasdaq-100

Autodesk (ADSK) is a Technology company in the Software Application industry. It has a market capitalization of $54.70B, a trailing price-to-earnings ratio of 22.2 and a free-cash-flow yield of 4.2%. Over the most recent reported fiscal year, revenue grew 17.5% and free cash flow per share grew 59.3%. Nama's AI scorecard rates it Buy, 8.2 out of 10. On 12-month momentum it ranks in the trailing band of its market.

AI scorecard

Buy · 8.2/10

Clearly positive, short of the top band. As of Nov 7, 2026.

Momentum

Trailing · -20.3% over 12 months ex. last

Bottom 20% of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-22.0%

How far the last close sits under the highest price of the past five years.

Market cap	$54.70B
Trailing P/E	22.2
Price / book	16.2
Price / sales	7.0
FCF yield	4.2%
Dividend yield	—
Gross margin	91.2%
Operating margin	27.9%
Net margin	21.1%
Revenue growth (YoY)	+17.5%
Revenue growth (3-yr annual)	+12.9%
EPS growth (YoY)	+23.0%
FCF/share growth (YoY)	+59.3%
Beta	1.3
Exchange	NASDAQ
Sector	Technology
Industry	Software Application

ADSK earnings

Next report: Nov 27, 2026 (Q3 2027, EPS estimate $3.07). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2027	Aug 27, 2026	$3.30	$3.12	+5.8%	$2.05B
Q1 2027	May 28, 2026	$2.99	$2.84	+5.3%	$1.93B
Q4 2026	Feb 26, 2026	$2.85	$2.64	+8.0%	$1.96B
Q3 2026	Nov 25, 2025	$2.67	$2.50	+6.8%	$1.85B

ADSK analyst price target

Median target $302.50 from 34 analysts, ranging $215.00 – $375.00.

Software Application peers

Ticker	Company	Market cap	P/E
SAP	SAP	$269.45B	29.7
SHOP	Shopify	$191.58B	85.1
CRM	Salesforce	$175.83B	12.7
UBER	Uber Technologies	$140.05B	40.6
ADP	Automatic Data Processing	$119.75B	26.5
NOW	ServiceNow	$105.84B	26.9
SNOW	Snowflake	$97.33B	195.7
ADBE	Adobe	$93.14B	10.1

Explore live ADSK data on Nama Insights →

Recent Congressional trades

Autodesk trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025
Jefferson Shreve	House	Sell	$15,001 - $50,000	Jun 22, 2025
Jefferson Shreve	House	Buy	$15,001 - $50,000	May 8, 2025
Byron Donalds	House	Buy	$1,001 - $15,000	Apr 14, 2025
Byron Donalds	House	Buy	$1,001 - $15,000	Apr 14, 2025
Jefferson Shreve	House	Sell	$15,001 - $50,000	Apr 11, 2025
Lois Frankel	House	Sell	$1,001 - $15,000	Oct 10, 2023

ADSK FAQ

Is ADSK a buy?: Nama's AI scorecard currently rates Autodesk Buy (8.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ADSK's P/E ratio?: Autodesk trades at a trailing price-to-earnings ratio of 22.2.
When does ADSK report earnings?: Autodesk's next scheduled report is on Nov 27, 2026. Analysts expect EPS of $3.07.
What is the ADSK price target?: The median analyst price target from 34 analysts is $302.50, with a range of $215.00 – $375.00.
Is ADSK Shariah compliant?: Nama's AAOIFI-style screen reads Autodesk as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.